Patients with atrial fibrillation now live longer after stroke, heart failure, or myocardial infarction, but bleeding risks ...

Delays in providing first medical contact to device time for STEMI can result in worse patient outcomes, highlighting the ...

Researchers from the Germans Trias i Pujol research institute (IGTP) have conducted a preclinical study on the effects of the ...

A study has shown that patients who have experienced acute myocardial infarction have a higher risk of developing blood ...

Semaglutide appears to reduce the risk of death, heart attack and stroke in adults with type 2 diabetes more effectively than ...

Patients with AAV are associated with an increased risk for MI, particularly during the first 3 months after diagnosis.

CARDIOVASCULAR diseases (CVDs) continue to be the leading cause of death in the Philippines, with access to timely and ...

A new study published in the Journal of American Medical Association showed that switching from ticagrelor to clopidogrel one month after percutaneous coronary intervention (PCI) for ...

Bottom line of study: SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney ...